According to the New York Times, the curtain is expected to come down next week on a monopoly for the anti-inflammatory medication, Humira, that has generated $114 billion in revenue for AbbVie just since the end of 2016. Questions: Source: Robbins, R. (2023). How a Drug Company Made $114 Billion by Gaming the U.S. Patent… Read more »